ArticlePharmaceuticals (Basel, Switzerland)2023

Assessment of Aptamer as a Potential Drug Targeted Delivery for Retinal Angiogenesis Inhibition.

David Moreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.